The Erchonia® FX405 represents the next evolution in low-level laser therapy (LLLT), combining 635nm red laser technology with an innovative 405nm violet laser wavelength to deliver advanced, non-invasive pain management. Designed for busy healthcare professionals, the FX405 offers fully automated, hands-free treatments that improve workflow, increase treatment capacity, and provide patients with a comfortable, drug-free option for pain relief.

Whether you’re a chiropractor, physiotherapist, sports medicine clinic, podiatrist, pain management specialist, rehabilitation clinic, or multidisciplinary practice, the FX405 can become one of the most profitable and efficient technologies in your office.

Erchonia has invested decades in clinical research supporting low-level laser therapy. The company states it holds numerous FDA clearances for non-thermal laser devices across different indications, with many studies designed as randomized, double-blind, placebo-controlled, multi-center clinical trials. The FX405 builds on this body of research by combining red and violet wavelengths in a fully automated platform.

The Erchonia FX405 is a true low-level laser therapy (LLLT) system that utilizes four rotating laser diodes to deliver precise, non-thermal laser energy over a large treatment area. Unlike high-powered surgical lasers, the FX405 does not generate heat or damage tissue. Instead, it stimulates normal cellular processes that support healing and pain reduction.

The FX405 combines:

• 635nm Red Laser
• 405nm Violet Laser
• Fully automated scanning technology
• Hands-free operation
• Adjustable treatment protocols

This combination allows clinicians to efficiently treat acute and chronic musculoskeletal conditions while minimizing staff involvement. The addition of the 405nm wavelength is intended to provide broader biological effects than red light alone, including antimicrobial properties and complementary cellular stimulation.

Every cell in the body relies on energy in the form of ATP (Adenosine Triphosphate) to function properly.

The FX405 delivers specific wavelengths of laser light that are absorbed by cellular components within the mitochondria. This photochemical interaction helps optimize cellular energy production and supports normal tissue repair processes.

The result is improved cellular performance that may help:

• Reduce inflammation
• Support tissue healing
• Improve circulation
• Enhance recovery
• Reduce pain
• Restore function

Unlike therapies that simply mask symptoms, low-level laser therapy works by stimulating natural biological processes without heat or tissue destruction. The FX405’s dual-wavelength design is intended to stimulate multiple cellular pathways while providing non-thermal treatment.

The FX 405 laser scanner offers all of the same benefits that the FX 635 does, with the advantage of adding violet laser for versatility in treatments.

In addition to the violet laser’s anti-bacterial and anti-microbial properties, it also produces more energy per photon which research shows that the combination of violet and red lasers results in greater pain relief. The violet laser also enhances reactive oxygen species (ROS), which plays an important role in facilitating pain and inflammation reduction.

Indications for Use: – K231409

• The Erchonia® FX-405 laser is generally indicated:
  While using the red and violet diodes, for the adjunctive use in providing temporary relief of nociceptive musculoskeletal pain.
• And while using the red diodes, as an adjunctive treatment of postoperative pain.

*Device intended for Medical Professionals
*Prescription Use (Part 21 CFR 801 Subpart D)